StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$0.99−0.01 (-0.91%)

Close on Nov 18, 2026Market cap $636.63MP/E –Yield –

Geron revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Geron's revenue for the twelve months ending Sep 30, 2024 was $29.48M, up 9199.7% year over year. For fiscal 2023 it was $237.00K, down 60.2% from the year before. Over ten years it grew -15.5% a year on average. The highest annual figure on record is $36.37M in fiscal 2015.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$237.00K-60.2%
FY2022Dec 31, 2022$596.00K-57.2%
FY2021Dec 31, 2021$1.39M+450.6%
FY2020Dec 31, 2020$253.00K-45.0%
FY2019Dec 31, 2019$460.00K-56.8%
FY2018Dec 31, 2018$1.07M+0.1%
FY2017Dec 31, 2017$1.07M-82.7%
FY2016Dec 31, 2016$6.16M-83.1%
FY2015Dec 31, 2015$36.37M+3054.5%
FY2014Dec 31, 2014$1.15M-10.1%
FY2013Dec 31, 2013$1.28M-52.6%
FY2012Dec 31, 2012$2.71M+11.1%
FY2011Dec 31, 2011$2.44M-31.6%
FY2010Dec 31, 2010$3.56M+106.4%
FY2009Dec 31, 2009$1.73M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$57.48M+45.1%
Q1 FY2026Mar 31, 2026$51.84M+83.4%
Q3 FY2025Sep 30, 2025$47.23M+5254.5%
Q2 FY2025Jun 30, 2025$49.04M+16030.3%
Q1 FY2025Mar 31, 2025$39.60M+172087.0%
Q3 FY2024Sep 30, 2024$28.27M+17138.4%
Q2 FY2024Jun 30, 2024$882.00K+2941.4%
Q1 FY2024Mar 31, 2024$304.00K+1347.6%
Q4 FY2023Dec 31, 2023$23.00K-77.7%
Q3 FY2023Sep 30, 2023$164.00K-44.8%
Q2 FY2023Jun 30, 2023$29.00K-60.3%
Q1 FY2023Mar 31, 2023$21.00K-82.9%
Q4 FY2022Dec 31, 2022$103.00K-90.1%
Q3 FY2022Sep 30, 2022$297.00K+172.5%
Q2 FY2022Jun 30, 2022$73.00K-31.8%
Q1 FY2022Mar 31, 2022$123.00K-10.2%
Q4 FY2021Dec 31, 2021$1.04M+1980.0%
Q3 FY2021Sep 30, 2021$109.00K+0.9%
Q2 FY2021Jun 30, 2021$107.00K+148.8%
Q1 FY2021Mar 31, 2021$137.00K+163.5%
Q4 FY2020Dec 31, 2020$50.00K-70.8%
Q3 FY2020Sep 30, 2020$108.00K-17.6%
Q2 FY2020Jun 30, 2020$43.00K-57.4%
Q1 FY2020Mar 31, 2020$52.00K-8.8%
Q4 FY2019Dec 31, 2019$171.00K-54.4%
Q3 FY2019Sep 30, 2019$131.00K-20.6%
Q2 FY2019Jun 30, 2019$101.00K-51.4%
Q1 FY2019Mar 31, 2019$57.00K-82.1%
Q4 FY2018Dec 31, 2018$375.00K+96.3%
Q3 FY2018Sep 30, 2018$165.00K+1.2%
Q2 FY2018Jun 30, 2018$208.00K+19.5%
Q1 FY2018Mar 31, 2018$318.00K-40.8%
Q4 FY2017Dec 31, 2017$191.00K+103.2%
Q3 FY2017Sep 30, 2017$163.00K-96.8%
Q2 FY2017Jun 30, 2017$174.00K–
Q1 FY2017Mar 31, 2017$537.00K–
Q4 FY2016Dec 31, 2016$94.00K–
Q3 FY2016Sep 30, 2016$5.11M–

More Geron figures

See a number that looks wrong?